These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2111931)

  • 1. Efficient use of endpoints in clinical trials: a clinical perspective.
    Terrin ML
    Stat Med; 1990; 9(1-2):155-60. PubMed ID: 2111931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the costs of a large prevention trial.
    Urban N; Self S; Kessler L; Prentice R; Henderson M; Iverson D; Thompson D; Byar D; Insull W; Gorbach SL
    Control Clin Trials; 1990 Apr; 11(2):129-46. PubMed ID: 2161311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial and economic evaluation.
    Jain S; Arora NK
    Indian J Pediatr; 2000 May; 67(5):363-8. PubMed ID: 10885210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective.
    Prentice RL
    Stat Med; 1990; 9(1-2):161-70; discussion 170-2. PubMed ID: 2345832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative costs and activity from a sample of UK clinical trials units.
    Hind D; Reeves BC; Bathers S; Bray C; Corkhill A; Hayward C; Harper L; Napp V; Norrie J; Speed C; Tremain L; Keat N; Bradburn M
    Trials; 2017 May; 18(1):203. PubMed ID: 28464930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
    Gustavsson A; Cattelin F; Jönsson L
    Alzheimers Dement; 2011 Jul; 7(4):466-73. PubMed ID: 21784355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of unequal randomisation to aid the economic efficiency of clinical trials.
    Torgerson DJ; Campbell MK
    BMJ; 2000 Sep; 321(7263):759. PubMed ID: 10999916
    [No Abstract]   [Full Text] [Related]  

  • 8. Unequal randomisation can improve the economic efficiency of clinical trials.
    Torgerson D; Campbell M
    J Health Serv Res Policy; 1997 Apr; 2(2):81-5. PubMed ID: 10180369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large streamlined trials in cardiovascular disease.
    Calvo G; McMurray JJ; Granger CB; Alonso-García Á; Armstrong P; Flather M; Gómez-Outes A; Pocock S; Stockbridge N; Svensson A; Van de Werf F
    Eur Heart J; 2014 Mar; 35(9):544-8. PubMed ID: 24385376
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis and interpretation of cost data in randomised controlled trials: review of published studies.
    Barber JA; Thompson SG
    BMJ; 1998 Oct; 317(7167):1195-200. PubMed ID: 9794854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient design of clinical trials and epidemiological research: is it possible?
    Lauer MS; Gordon D; Wei G; Pearson G
    Nat Rev Cardiol; 2017 Aug; 14(8):493-501. PubMed ID: 28447664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
    Chen MH; Willan AR
    Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials.
    Coyle D; Davies L; Drummond MF
    Int J Technol Assess Health Care; 1998; 14(1):135-44. PubMed ID: 9509801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
    Backhouse ME
    Pharmacoeconomics; 2002; 20(15):1061-77. PubMed ID: 12456201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials.
    Detsky AS
    Stat Med; 1990; 9(1-2):173-84. PubMed ID: 2111932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discussion of papers on cost and efficiency of data collection in clinical trials.
    Ellenberg SS
    Stat Med; 1990; 9(1-2):145-8; discussion 148-51. PubMed ID: 2345831
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost and efficiency in clinical trials: the U.S. Physicians' Health Study.
    Buring JE; Hennekens CH
    Stat Med; 1990; 9(1-2):29-33. PubMed ID: 2345836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the funding challenge: the cost of randomized controlled trials in the next decade.
    Shore BJ; Nasreddine AY; Kocher MS
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():101-6. PubMed ID: 22810458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.